Stockscreener 앱 받기
7.28
3.45%
-0.26
시장 영업 전:
7.18
-0.10
-1.37%
Achieve Life Sciences Inc 주식(ACHV)의 최신 뉴스
Bank of New York Mellon Corp Buys Shares of 218,126 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Wellington Management Group LLP Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Frazier Life Sciences Management L.P. Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Stock Price Forecast. Should You Buy ACHV? - StockInvest.us
Achieve Life Sciences Grants Equity Awards to 7 New Employees Under 2024 Inducement Plan - Quiver Quantitative
Seven new employees receive stock awards from Achieve Life Sciences - Stock Titan
Achieve Life Sciences (NASDAQ:ACHV) Sets New 1-Year HighHere's What Happened - MarketBeat
BlackRock Inc. Invests $34.43 Million in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Up 5.2%Time to Buy? - MarketBeat
Alyeska Investment Group L.P. Acquires Shares of 1,925,722 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Jupiter Topco LLC Acquires Shares of 2,751,032 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Inc. (ACHV) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Spruce Street Capital LP Purchases Shares of 736,637 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Inc. (ACHV) Key Financial Ratios – Valuation, Profitability & More - Value Research
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
This Insider Has Just Sold Shares In Achieve Life Sciences - simplywall.st
Insider Selling: Achieve Life Sciences (NASDAQ:ACHV) Director Sells $175,114.74 in Stock - MarketBeat
Achieve Life (NASDAQ: ACHV) director keeps 208,249 shares after sale - Stock Titan
Achieve Life (NASDAQ: ACHV) director to sell 20,626 shares - Stock Titan
Achieve Life Sciences (NASDAQ:ACHV) Sets New 12-Month HighShould You Buy? - MarketBeat
Achieve Life Sciences (ACHV) draws new passive holder near 10% - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Achieve Life Sciences Inc (ACHV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Achieve Life Sciences (NASDAQ:ACHV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Achieve Life SciencesEnters ATM Sale Agreement With Jefferies For Up To $150 Million In Common Stock - TradingView
Achieve Life Sciences (ACHV) launches $150M at-the-market stock program - Stock Titan
Achieve Life Sciences, Inc. (NASDAQ:ACHV): When Will It Breakeven? - Moomoo
Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near? - simplywall.st
(08/14/26) ACHV: A Speculative Trade in the Biotech Sector - moneyshow.com
ACHV Q1 2026 Earnings: Smaller-Than-Expected Loss Lifts Shares 8.37%Long-Term Guidance - vinanet.vn
Janus Henderson Group (ACHV) reports 5,502,064 Achieve Life shares under management - Stock Titan
This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Achieve Life Sciences' Cytisinicline to Unlock $760 Million Market Opportunity in Smoking Cessation, Morgan Stanley Says - marketscreener.com
Achieve Life Sciences, Inc. Stock 12‑Month Price Target Cut to $13.83, Implies 107% Upside - TradingView
Achieve Life Sciences (NASDAQ:ACHV) Hits New 12-Month HighHere's Why - MarketBeat
Achieve stock gains Overweight at Morgan Stanley (ACHV:NASDAQ) - Seeking Alpha
HC Wainwright Has Optimistic Outlook of ACHV Q3 Earnings - MarketBeat
ACHV Initiates Coverage On by Morgan Stanley -- Rating Set to Ov - GuruFocus
Morgan Stanley Initiates Achieve Life Sciences at Overweight, With $13 Price Target - marketscreener.com
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit. - webull.com
Morgan Stanley initiates Achieve Life Sciences stock at overweight By Investing.com - Investing.com Nigeria
Morgan Stanley initiates Achieve Life Sciences stock at overweight - Investing.com
H.C. Wainwright reiterates Achieve Life Sciences stock rating at buy By Investing.com - Investing.com Canada
Research Analysts Set Expectations for ACHV FY2028 Earnings - MarketBeat
Achieve Life Sciences Submits Q2 2026 Form 10-Q Highlighting NDA Resubmission and Financial Risks - Kalkine Media
Achieve Life Sciences Releases Q2 2026 Financial Results - AlphaStreet
ACHIEVE LIFE SCIENCES, INC. 6M 2026: Net loss $(84.9)M, EPS $(1.15) — 10-Q Summary - TradingView
Achieve Life Sciences (ACHV) swings to larger $84.9M loss on warrant costs - stocktitan.net
Achieve Life Sciences (NASDAQ: ACHV) posts larger Q2 2026 loss but secures $354M financing - Stock Titan
FDA declines to approve Achieve smoking cessation drug; Q4 resubmission planned - scanx.trade
Achieve Life Sciences Q2 Results: EPS misses estimate, losses widen - scanx.trade
Achieve Life Sciences (NASDAQ:ACHV) Posts Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat
Achieve Life Sciences (ACHV) Advances Cytisinicline Commercializ - GuruFocus
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - marketscreener.com
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Achieve Life Sciences (ACHV) - The Globe and Mail
ACHV Edges Higher to $6.67 as Achieve Life Sciences Consolidates Between Support and ResistanceMFI Oversold - vinanet.vn
Achieve Life Sciences Inc (ACHV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ACHV Q2'26 Earnings: EPS estimate is (0.16) USD - TradingView
Achieve Life Sciences (ACHV) Holds Gains at $6.39 as Biotech Momentum BuildsMarket Leader Picks - vinanet.vn
Achieve Life Sciences Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
3.04%
자본화:
|
볼륨(24시간):